RAP-219

· Rapport Therapeutics Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for RAP-219, covering 2026-01-23 to 2026-04-02. Get the full timeline:

Most recent: Clinical Trial Update: Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Bipolar I Disorder [Phase 2]